株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

注入型コネクテッドドラッグデリバリーデバイス市場の予測:従来型デバイス・自己注入型デバイス・その他

Connected Injectable Drug Delivery Devices Market - Forecast (2020 - 2025)

発行 IndustryARC 商品コード 622669
出版日 ページ情報 英文 112 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.96円で換算しております。
注入型コネクテッドドラッグデリバリーデバイス市場の予測:従来型デバイス・自己注入型デバイス・その他 Connected Injectable Drug Delivery Devices Market - Forecast (2020 - 2025)
出版日: 2020年03月11日 ページ情報: 英文 112 Pages
概要

当レポートでは、世界の注入型コネクテッドドラッグデリバリーデバイスの市場を調査し、市場の定義と概要、競合環境と市場シェア、市場への各種影響因子および市場機会の分析、バリューチェーン、製品ライフサイクルの分析、デバイスタイプ・技術・用途・エンドユーザー・地域/主要国別の動向と市場規模の推移と予測、主要企業のプロファイルなどをまとめています。

第1章 市場概要

第2章 エグゼクティブサマリー

第3章 市場環境

  • 市場シェア分析
  • 競合事業者の分析
    • 製品ベンチマーキング
    • エンドユーザーのプロファイル
    • トップ5社の財務分析
    • 特許分析

第4章 市場影響因子

  • 成長推進因子
  • 成長阻害因子・課題
  • ポーターのファイブフォース分析

第5章 戦略的市場分析

  • バリューチェーン分析
  • 価格分析
  • 市場機会の分析
  • 製品・市場ライフサイクル

第6章 市場分析・予測:デバイスタイプ別

  • イントロダクション
  • 吸入器
  • 注射器
    • ハンドヘルドデバイス
    • ウェアラブルデバイス
  • 固形剤形
  • その他

第7章 市場分析・予測:技術別

  • イントロダクション
  • Bluetooth
  • スマートフォンアプリ
  • NFC
  • 緊急技術

第8章 市場分析・予測:用途別

  • イントロダクション
  • 糖尿病
  • 心血管疾患
  • 自己免疫疾患
  • ホルモン補充
  • 神経科
  • 依存症
  • 呼吸器系疾患
  • その他

第9章 市場分析・予測:エンドユーザー別

  • イントロダクション
  • 病院
  • 診療所
  • 在宅ケア

第10章 市場分析・予測:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア&ニュージーランド
    • その他
  • その他の地域
    • 南米
    • 中東
    • アフリカ

第11章 市場エントロピー

  • 拡張
  • 技術開発
  • M&A・JV
  • 供給契約

第12章 企業プロファイル

  • Phillips-Medisize Corporation
  • West Pharmaceutical Services, Inc.
  • Biocorp
  • Aterica, Inc.
  • Unilife Corporation
  • パナソニック
  • Propeller Health
  • Qualcomm Technologies, Inc.
  • Haselmeier
  • SHL Group

第13章 付録

目次
Product Code: HCR 1211

Connected Injectable Drug Delivery Devices Market Overview

Self-administration of drugs through pre-filled syringes is one of the different ways that is helping patients save the fees given to a caregiver. The global connected injectable drug delivery devices market is estimated to surpass $22,814m by 2023, growing at an estimated CAGR of 6.8% from 2018 to 2023.The Europe region is the largest market for connected injectable drug delivery devices owing to the large customer pool.

Connected Injectable Drug Delivery Devices Market Outlook

Connected injectable drug delivery devices record the dosing pattern of patients and makes it available to healthcare professionals. These drug delivery devices help in addressing patient's issues with regard to medications, treatments, and disease management protocols that are of major concern for professionals in the healthcare and pharmaceutical industries. Before bringing a connected health offering to life, it is important to understand the fundamentals of patient-centric design. One of the most successful elements in fulfilling the need for patient-centric design is human factors analysis, which benefits the patient by making injection systems more comfortable and user-friendly.

This report provides an in-depth analysis of the connected injectable drug delivery devices market by delivery devices type, connectivity technology, by disease, and by geography. On the basis of delivery devices type, the market is categorized into conventional injection devices, self-injection devices, and others. On the basis of connectivity technology, the market is segmented into wireless technology, Bluetooth, near infrared technology, and smart phone apps. Based on disease, the market is categorized into anaphylaxis, autoimmune disease, cardiovascular, diabetes, hormone replacement, and others.

Connected Injectable Drug Delivery Devices Market Growth Drivers

The market is forecast to be majorly driven by the increase in cases of chronic diseases like rheumatoid arthritis, cardiovascular disease, cancer and diabetes. The increasing concern of the pharmaceutical or medical devices companies towards development of connected injectable drug delivery devices is expected to drive the connected injectable drug delivery devices market.

Connected Injectable Drug Delivery Devices Market Challenges

The regulatory hurdles due to high requirement of data and evidences for developing new technologies and recent product recalls by the FDA are restraining the growth of the connected injectable drug delivery devices market. High cost of these connected injectable drug delivery devices and data security and privacy issues are also hindering the market growth.

Connected Injectable Drug Delivery Devices Market Research Scope

The base year of the study is 2017, with forecast done up to 2023. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the connected injectable drug delivery devices market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to measure their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of delivery devices, and connectivity technology in the connected injectable drug delivery devices market.

Connected Injectable Drug Delivery Devices Market Report: Industry Coverage

Delivery devices type in Connected Injectable Drug Delivery Devices: Conventional Injection Devices, Self-Injection Devices, and Others

Connectivity technology in Connected Injectable Drug Delivery Devices: Wireless Technology, Bluetooth, Near Field Technology, and Smart Phone Apps

Diseases in Connected Injectable Drug Delivery Devices: Anaphylaxis, Autoimmune Disease, Cardiovascular, Diabetes, Hormone Replacement, and Others

The Connected Injectable Drug Delivery Devices Market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

North America: The U.S., Canada, Mexico

South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

The Middle East and Africa: Israel, South Africa, Saudi Arabia

Connected Injectable Drug Delivery Devices Market Key Players Perspective

Some of the key players mentioned in this report are Ypsomed Holdings, Unolife Corporation, Quio Technologies, SHL Group, Biocorp, Haselmeier Inc., and West Pharmaceutical Services, Inc.

Connected Injectable Drug Delivery Devices Market Trends

Rising prevalence of multiple sclerosis and rheumatoid arthritis will also impact the connected injectable drug delivery devices market.

Rising incidence of diabetes globally will also propel the growth of the connected injectable drug delivery devices market

Conventional injection devices accounted for the major share of the total market in 2017.

As per IndustryARC analysis, the conventional injection devices segment will generate substantial revenue by 2023. The advancement in technology and rising incidences of rheumatoid arthritis and multiple sclerosis are set to drive the market in the next few years.

1. Connected Injectable Drug Delivery Devices Market - Overview

  • 1.1. Definitions and Scope

2. Connected Injectable Drug Delivery Devices Market - Executive summary

  • 2.1. Market Revenue, Market Size and Key Trends by Company
  • 2.2. Key Trends by type of Application
  • 2.3. Key Trends segmented by Geography

3. Connected Injectable Drug Delivery Devices Market

  • 3.1. Comparative analysis
    • 3.1.1. Product Benchmarking - Top 8 companies
    • 3.1.2. Top 5 Financials Analysis
    • 3.1.3. Market Value split by Top 8 companies
    • 3.1.4. Patent Analysis - Top 8 companies
    • 3.1.5. Pricing Analysis

4. Connected Injectable Drug Delivery Devices Market Forces

  • 4.1. Drivers
  • 4.2. Constraints
  • 4.3. Challenges
  • 4.4. Porters five force model
    • 4.4.1. Bargaining power of suppliers
    • 4.4.2. Bargaining powers of customers
    • 4.4.3. Threat of new entrants
    • 4.4.4. Rivalry among existing players
    • 4.4.5. Threat of substitutes

5. Connected Injectable Drug Delivery Devices Market -Strategic analysis

  • 5.1. Value chain analysis
  • 5.2. Opportunities analysis
  • 5.3. Product life cycle
  • 5.4. Suppliers and distributors Market Share

6. Connected Injectable Drug Delivery Devices Market - By Delivery Devices Type (Market Size -$Million / $Billion)

  • 6.1. Market Size and Market Share Analysis
  • 6.2. Application Revenue and Trend Research
  • 6.3. Product Segment Analysis
    • 6.3.1. Conventional Injection Devices
    • 6.3.2. Self-Injection Devices
      • 6.3.2.1. Pen Injectors
      • 6.3.2.2. Needle Free Injectors
      • 6.3.2.3. Auto Injectors
    • 6.3.3. Others

7. Connected Injectable Drug Delivery Devices Market - By Connectivity Technology (Market Size -$Million / $Billion)

  • 7.1. Introduction
  • 7.2. Wireless Technology
  • 7.3. Bluetooth
  • 7.4. Near Field Technology
  • 7.5. Smart Phone Apps

8. Connected Injectable Drug Delivery Devices Market - By Disease (Market Size -$Million / $Billion)

  • 8.1. Introduction
  • 8.2. Anaphylaxis
  • 8.3. Autoimmune Disease
  • 8.4. Cardiovascular
  • 8.5. Diabetes
  • 8.6. Hormone Replacement
  • 8.7. Others

9. Connected Injectable Drug Delivery Devices - By Geography (Market Size -$Million / $Billion)

  • 9.1. Connected Injectable Drug Delivery Devices Market - North America Segment Research
  • 9.2. North America Market Research (Million / $Billion)
    • 9.2.1. Segment type Size and Market Size Analysis
    • 9.2.2. Revenue and Trends
    • 9.2.3. Application Revenue and Trends by type of Application
    • 9.2.4. Company Revenue and Product Analysis
    • 9.2.5. North America Product type and Application Market Size
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
      • 9.2.5.4. Rest of North America
  • 9.3. Connected Injectable Drug Delivery Devices - South America Segment Research
  • 9.4. South America Market Research (Market Size -$Million / $Billion)
    • 9.4.1. Segment type Size and Market Size Analysis
    • 9.4.2. Revenue and Trends
    • 9.4.3. Application Revenue and Trends by type of Application
    • 9.4.4. Company Revenue and Product Analysis
    • 9.4.5. South America Product type and Application Market Size
      • 9.4.5.1. Brazil
      • 9.4.5.2. Venezuela
      • 9.4.5.3. Argentina
      • 9.4.5.4. Ecuador
      • 9.4.5.5. Peru
      • 9.4.5.6. Colombia
      • 9.4.5.7. Costa Rica
      • 9.4.5.8. Rest of South America
  • 9.5. Connected Injectable Drug Delivery Devices - Europe Segment Research
  • 9.6. Europe Market Research (Market Size -$Million / $Billion)
    • 9.6.1. Segment type Size and Market Size Analysis
    • 9.6.2. Revenue and Trends
    • 9.6.3. Application Revenue and Trends by type of Application
    • 9.6.4. Company Revenue and Product Analysis
    • 9.6.5. Europe Segment Product type and Application Market Size
      • 9.6.5.1. U.K
      • 9.6.5.2. Germany
      • 9.6.5.3. Italy
      • 9.6.5.4. France
      • 9.6.5.5. Netherlands
      • 9.6.5.6. Belgium
      • 9.6.5.7. Spain
      • 9.6.5.8. Denmark
      • 9.6.5.9. Rest of Europe
  • 9.7. Connected Injectable Drug Delivery Devices - APAC Segment Research
  • 9.8. APAC Market Research (Market Size -$Million / $Billion)
    • 9.8.1. Segment type Size and Market Size Analysis
    • 9.8.2. Revenue and Trends
    • 9.8.3. Application Revenue and Trends by type of Application
    • 9.8.4. Company Revenue and Product Analysis
    • 9.8.5. APAC Segment - Product type and Application Market Size
      • 9.8.5.1. China
      • 9.8.5.2. Australia
      • 9.8.5.3. Japan
      • 9.8.5.4. South Korea
      • 9.8.5.5. India
      • 9.8.5.6. Taiwan
      • 9.8.5.7. Malaysia

10. Connected Injectable Drug Delivery Devices Market - Entropy

  • 10.1. New product launches
  • 10.2. M&A's, collaborations, JVs and partnerships

11. Connected Injectable Drug Delivery Devices Market Company Analysis

  • 11.1. Market Share, Company Revenue, Products, M&A, Developments
  • 11.2. Ypsomed Holdings
  • 11.3. Unolife Corporation
  • 11.4. Quio Technologies
  • 11.5. SHL Group
  • 11.6. Biocorp
  • 11.7. Haselmeier Inc.
  • 11.8. West Pharmaceutical Services Inc.
  • 11.9. Company 8
  • 11.10. Company 9
  • 11.11. Company 10 and more

"*Financials would be provided on a best efforts basis for private companies"

12. Connected Injectable Drug Delivery Devices Market -Appendix

  • 12.1. Abbreviations
  • 12.2. Sources